Las Vegas, NV -- (SBWIRE) -- 10/08/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, ProShares Trust II (NYSEARCA:UVXY), iShares IBoxx $ Invest Grade Corp Bd Fd (NYSEARCA:LQD), Donegal Group Inc. (NASDAQ:DGICB), Apricus Biosciences Inc (NASDAQ:APRI)
ProShares Trust II (NYSEARCA:UVXY) opened the session at $38.86, remained amid the day range of $37.90 - $41.47, and closed the session at $41.31. The stock showed a positive performance of 14.91% in previous trading session. The stock gained a volume of 1.55 million shares.
For How Long UVXY will fight for Profitability? Read This Trend Analysis report
iShares IBoxx $ Invest Grade Corp Bd Fd (NYSEARCA:LQD) traded with volume of 216,048 shares in the prior session. The 52 week range of the stock remained $110.74 - $123.20. The stock showed a positive movement of 0.18% and closed its session at $113.53. The market capitalization of the stock remained 17.09 billion. iShares iBoxx $ Investment Grade Corporate Bond ETF (the Fund), formerly iShares iBoxx $ Investment Grade Corporate Bond Fund, is an exchange-traded fund (ETF). The Fund seeks to track the investment results of the Markit iBoxx USD Liquid Investment Grade Index (the Index), which is a rules-based index consisting of liquid, the United States dollar-denominated, investment-grade corporate bonds for sale in the United States.
For How Long LQD Gloss will Attract Investors? Find out via this report
Donegal Group Inc. (NASDAQ:DGICB) exchanged 12,010 shares and the average volume remained 383 shares. The stock escalated 14.86 % and closed the session at $22.95. The beta of the stock remained 0.49 and the EPS of the stock remained 0.85. The shares outstanding of the stock remained 17.55 million. Donegal Group Inc. (DGI) is an insurance holding company whose insurance subsidiaries offer personal and commercial lines of property and casualty insurance to businesses and individuals in 22 Mid-Atlantic, Midwestern, New England and Southern states.
Will DGICB Continue To Move Higher? Find Out Here
Apricus Biosciences Inc (NASDAQ:APRI) gained volume of 1.27 million shares, while the average volume remained 178,078 shares. The stock advanced 14.78% and finished the session at $2.33. The EPS of the stock remained -0.89. The one month of the stock was 12.56% and three month trend remained positive 4.95 %.Apricus Biosciences, Inc. is in the pharmaceutical industry primarily focusing on research and development using its drug delivery technology called NexACT. The Company is actively engaged in acquiring companies and in-licensing drugs that will complement its product portfolio.
Why Should Investors Buy APRI After The Recent Gain? Just Go Here and Find Out
About:Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)